| Literature DB >> 27760327 |
Shuai Gao1, Yanfei Gao2, Housheng Hansen He3, Dong Han4, Wanting Han4, Amy Avery4, Jill A Macoska4, Xiaming Liu5, Sen Chen6, Fen Ma6, Shaoyong Chen7, Steven P Balk8, Changmeng Cai9.
Abstract
Although well characterized as a transcriptional activator that drives prostate cancer (PCa) growth, androgen receptor (AR) can function as a transcriptional repressor, and high-level androgens can suppress PCa proliferation. The molecular basis for this repression activity remains to be determined. Genes required for DNA replication are highly enriched among androgen-repressed genes, and AR is recruited to the majority of these genes, where it rapidly represses their transcription. This activity is enhanced in PCa cells expressing high AR levels and is mediated by recruitment of hypophosphorylated retinoblastoma protein (Rb). Significantly, AR also indirectly increases the expression of DNA replication genes through stimulatory effects on other metabolic genes with subsequent CDK activation and Rb hyperphosphorylation. In castration-resistant PCa cells, which are dependent on high-level AR expression, this anti-proliferative repression function might be exploited through treatment with androgen in combination with agents that suppress AR-driven metabolic functions or cell cycle progression.Entities:
Keywords: AR; DNA damage repair; DNA replication; E2F1; Rb; Retinoblastoma protein; androgen deprivation therapy; androgen receptor; metabolism; prostate cancer; transcriptional repression
Mesh:
Substances:
Year: 2016 PMID: 27760327 PMCID: PMC5123835 DOI: 10.1016/j.celrep.2016.09.064
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423